A copy of Obamacare repeal and replace recommendations (L) produced by Republicans in the U.S. House of Representatives sit next to a copy of the Affordable Care Act known as Obamacare as U.S. Health and Human Services Secretary Tom Price addresses the daily p... More »
A copy of Obamacare repeal and replace recommendations (L) produced by Republicans in the U.S. House of Representatives sit next to a copy of the Affordable Care Act known as Obamacare as U.S. Health and Human Services Secretary Tom Price addresses the daily p... More »
Speaker of the House Paul Ryan (R-WI) and House Majority Leader Kevin McCarthy (R-CA) speak about the American Health Care Act, the Republican replacement to Obamacare, at the Republican National Committee in Washington, U.S., March 8, 2017. REUTERS/Joshua Rob... More »
FILE PHOTO – The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration said Pfizer Inc’s process for manufacturing sterile injectable drugs at a plant... More »
The office building of health insurer Anthem is seen in Los Angeles, California February 5, 2015. REUTERS/Gus Ruelas Anthem Inc. (ANTM.N) and other U.S. health insurers complained to the White House for more than a year that they were losing money on people wh... More »
Shelves displaying medicines are seen at a pharmacy in Shanghai, China November 27, 2015. REUTERS/Aly Song/File Photo China has updated list of medicines covered by basic medical insurance schemes, a long-awaited fillip for drugmakers in the world’s second-lar... More »
The U.S. Justice Department has joined a whistleblower lawsuit against UnitedHealth Group Inc that claims the country’s largest health insurer and its units and affiliates overcharged Medicare hundreds of millions of dollars, a law firm representing the whistl... More »
FILE PHOTO – The federal government forms for applying for health coverage are seen at a rally held by supporters of the Affordable Care Act, widely referred to as ”Obamacare”, outside the Jackson-Hinds Comprehensive Health Center in Jackson, Mississippi, U.S.... More »
Merck & Co Inc said on Tuesday it will halt a late-stage trial of an Alzheimer’s drug after it was determined that it had no chance of working, marking the latest in a long line of crushing disappointments in efforts to find an effective treatment for the mind... More »
A DNA double helix is seen in an undated artist’s illustration released by the National Human Genome Research Institute to Reuters on May 15, 2012. REUTERS/National Human Genome Research Institute/Handout Powerful gene editing tools may one day be used on huma... More »
Marathon Pharmaceuticals LLC said on Monday it was “pausing” the launch of its Duchenne muscular dystrophy drug after U.S. lawmakers questioned why the company priced it at $89,000 a year when patients had been able to import it for as little as $1,000. More »
The office building of health insurer Anthem is seen in Los Angeles, California February 5, 2015. REUTERS/Gus Ruelas A federal judge on Wednesday ruled against U.S. health insurer Anthem Inc’s (ANTM.N) proposed $54 billion merger with smaller rival Cigna Corp ... More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo The U.S. Food and Drug Administration has approved Amgen Inc’s treatment for secondary hyperparathyroidism in adult ... More »
U.S. House Speaker Paul Ryan arrives on stage before President Donald Trump speaks during the 2017 ”Congress of Tomorrow” Joint Republican Issues Conference in Philadelphia, Pennsylvania, U.S. January 26, 2017. REUTERS/Mark Makela The U.S. House of Representat... More »
FILE PHOTO: U.S. President-elect Donald Trump speaks at his election night rally in Manhattan, New York, U.S., November 9, 2016. REUTERS/Carlo Allegri/File Photo President Donald Trump supports the government negotiating directly with drug companies on prices ... More »
European prices for some off-patent cancer drugs have risen by more than 100 percent in the past five years, with two cases of hikes exceeding 1,000 percent, according to data presented at a medical conference on Saturday. More »
Egypt’s military has received the license required to form a pharmaceutical company, a decree by Prime Minister Sherif Ismail published on Sunday showed. More »
U.S. President Donald Trump in Langley, Virginia, U.S. January 21, 2017. REUTERS/Carlos Barria President Donald Trump is ordering federal agencies to undermine Obamacare through regulatory action, a move that could weaken enforcement of the requirement for Ame... More »
U.S. President Donald Trump, flanked by Senior Advisor Jared Kushner (standing, L-R), Vice President Mike Pence and Staff Secretary Rob Porter welcomes reporters into the Oval Office for him to sign his first executive orders at the White House in Washington, ... More »
Merck & Co said it agreed to enter into a settlement and license agreement with Bristol-Myers Squibb Co and Ono Pharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda. More »
U.S. President-elect Donald Trump speaks during a news conference in the lobby of Trump Tower in Manhattan, New York City, U.S., January 11, 2017. REUTERS/Lucas Jackson U.S. President-elect Donald Trump aims to replace Obamacare with a plan that would envisage... More »
A bill repealing Obamacare sits on a desk after being signed by U.S. House Speaker Paul Ryan (R-WI) at the U.S. Capitol in Washington January 7, 2016. REUTERS/Jonathan Ernst U.S. House Republicans on Friday won passage of a measure starting the process of dism... More »
A majority of the U.S. House of Representatives on Friday voted to advance legislation instructing committees to write legislation repealing President Barack Obama’s landmark healthcare law. More »
Kite Pharma Inc said on Monday it partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments. More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration cle... More »
An artificial leaf designed by scientists at Eindhoven University of Technology, Netherlands December 16, 2016. REUTERS/Jim Drury Dutch scientists have developed an artificial leaf that can act as a mini-factory for producing drugs, an advance that could allow... More »
Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing. More »
Indian generic drugmaker Laurus Labs Ltd’s shares rose as much as 16.36 percent on their market debut on Monday after the company’s initial public offering raised $196.6 million. More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed U.S regulators said on Friday they would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces risk of death... More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic U.S. health spending in 2015 rose at its fastest rate since 2007, driven by expanded access to insurance under the A... More »
A woman stands near a poster explaining about the Zika virus at the Ministry of Health office in Jakarta, Indonesia September 2, 2016. REUTERS/Iqro Rinaldi/File Photo The World Health Organization on Friday declared that Zika no longer constitutes an internati... More »
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in Basel, Switzerland October 27, 2015. REUTERS/Arnd Wiegmann Drugmaker Novartis (NOVN.S) is considering to sell its struggling Alcon eye care division, its chairman said in... More »
A company logo is seen at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton Pfizer Inc’s Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and napro... More »
Taking medicines to lower blood pressure and cholesterol failed to prevent cognitive and functional declines in older adults with moderate risk of heart disease, according to results of a clinical trial presented on Sunday. More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo The world’s top drugmakers have improved access to medicines in developing countries but still need to do more to make a wider range of pro... More »
Scientists at Stanford University School of Medicine have used the CRISPR gene editing tool to repair the gene that causes sickle cell disease in stem cells from diseased patients, paving the way for a potential cure for the disease, which affects up to 5 mill... More »
U.S. Democratic presidential nominee Hillary Clinton listens as U.S. Senator Bernie Sanders speaks about college affordability during a campaign event at the University of New Hampshire in Durham, New Hampshire, United States September 28, 2016. REUTERS/Brian ... More »
A San Francisco-based hedge fund has filed a lawsuit against Theranos Inc, accusing the blood testing company of using fraudulent methods to attract an investment of nearly $100 million, according to an investor letter filed by the fund. More »
A trader passes by a screen displaying the tickers symbol for Bristol-Myers Squibb on the floor at the New York Stock Exchange, April 25, 2013. REUTERS/Brendan McDermid New data is likely to prompt doctors to abandon Bristol-Myers Squibb’s immunotherapy Opdivo... More »
The logo of healthcare company Johnson & Johnson is seen in front of an office building in Zug, Switzerland July 20, 2016. REUTERS/Arnd Wiegmann An experimental biotech drug developed by Johnson & Johnson proved more effective at clearing moderate to severe ca... More »
Big pharmaceutical companies are waging courtroom patent battles against each other over biosimilars, as the line blurs between companies known for their inn More »
An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file photo. REUTERS/Robert Galbraith/Files The line dividing makers of brand-name drugs and copycat medicines is blurring as companies known for innovativ... More »
The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira. More »
Ohio Governor John Kasich speaks as he withdraws as a U.S. Republican presidential candidate in Columbus, Ohio, U.S., May 4, 2016. REUTERS/Aaron Josefczyk Ohio’s Republican governor, John Kasich, took over the White House briefing lectern on Friday to praise t... More »
A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cov... More »
Aedes aegypti mosquitoes are seen at the Laboratory of Entomology and Ecology of the Dengue Branch of the U.S. Centers for Disease Control and Prevention in San Juan, Puerto Rico, March 6, 2016. REUTERS/Alvin Baez/File Photo State officials in Florida on Frida... More »
A British flag and an EU flag are seen in front of a monitor displaying a graph of the Japanese yen’s exchange rate against the U.S. dollar at a foreign exchange trading company in Tokyo, Japan, June 27, 2016. REUTERS/Toru Hanai Japan has warned Britain that i... More »
FILE PHOTO — U.S. Democratic presidential nominee Hillary Clinton speaks at Futuramic Tool & Engineering in Warren, Michigan August 11, 2016. REUTERS/Chris Keane/File Photo Hillary Clinton said on Friday that if elected to the White House she would create an o... More »
Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann Swiss drugmaker Roche (ROG.S) said on Monday the U.S. Food and Drug Administration (FDA) had issued an Emergency Use Authorization (EUA) fo... More »
U.S. President Barack Obama delivers remarks about health insurance marketplace enrollments and the Affordable Care Act, commonly known as Obamacare, in Milwaukee, Wisconsin March 3, 2016. REUTERS/Jonathan Ernst Nearly a third of U.S. counties will likely be s... More »
NEW YORK/SAN FRANCISCO U.S. prosecutors have opened a criminal investigation into Valeant Pharmaceuticals International Inc (VRX.N) over whether it hid from insurers its relationship with a specialty pharmacy that helped boost its drug sales, the Wall Street J... More »
SHANGHAI China health authorities have started a nationwide inspection of vaccinations four months after a scandal broke involving nearly $90 million worth of illegal vaccines that were suspected of being sold in dozens of provinces. Authorities will track pur... More »
CHICAGO A new type of cancer drug that takes the brakes off the body’s immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach. Dr. Richard Pazdur, he... More »
RIO DE JANEIRO Brazil’s Health Minister Ricardo Barros said on Friday there is no scientific basis for postponing the Olympics because of the Zika virus, explaining that lower temperatures and fewer mosquitoes reduced the chance of infection in August when the... More »
GENEVA/NEW YORK With debate growing over the safety of holding the Olympics in Brazil amid the ongoing Zika virus outbreak, the World Health Organization’s Emergency Committee on Zika will meet in the coming weeks to evaluate the risks tied to going on with th... More »
U.S. Food and Drug Administration staff released voting questions on Teva Pharmaceutical Industries Ltd’s long-acting opioid painkiller for a panel of independent experts who will recommend to the agency whether to approve the drug. An FDA spokesman on Friday ... More »
An experimental, long-acting painkiller made by Teva Pharmaceutical Industries Ltd does not have abuse-resistant properties when taken orally, according to a preliminary review by the U.S. Food and Drug Administration. The drug, whose proposed trade name is Va... More »
An experimental once-daily combination hepatitis C treatment being developed by AbbVie Inc demonstrated very high cure rates across a wide range of disease genotypes, according to data presented on Saturday, likely giving the company a more competitive product... More »
SEOUL Samsung Bioepis Co Ltd, which aims to become a force in the fledgling biosimilar drugs industry, has filed a lawsuit against the originator of the world’s best-selling drug, to stop it blocking the launch of its own version. The unit of South Korea’s Sam... More »
CONAKRY/MONROVIA Guinea will soon vaccinate people who have come into contact with more than 500 men who have recovered from Ebola, a senior health official said, the first time it has vaccinated the contacts of survivors. The decision reflects research that i... More »
MUMBAI A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities. A Reuters investigation revealed in December that a unit ... More »
SHANGHAI China’s drug regulator said it would accelerate approvals of new medicines, long a headache for pharmaceutical firms who complain it takes too long to get drugs to market. The China Food and Drug Administration (CFDA) said in a statement published on ... More »
Global health officials are racing to better understand the Zika virus behind a major outbreak that began in Brazil last year and has since spread to many countries in the Americas. The following are some questions and answers about the virus and current outbr... More »
LONDON Scientists in Britain have found how drug-resistant bacteria build and maintain a defensive wall — a discovery that paves the way for the development of new drugs to break through the barrier and kill the often deadly “superbugs”. In recent decades, bac... More »
PLYMOUTH, N.H. U.S. Republican presidential candidate Donald Trump came to the small town of Plymouth in the New Hampshire mountains on Sunday and promised to lower prescription drug prices, improve education and help heroin addicts get treatment. It was a day... More »
NEW YORK The tumble in share prices for biotechnology stocks has created some buying opportunities, with drugmakers Celgene Corp (CELG.O) and Gilead Sciences (GILD.O) poised for a 30 percent rise over the next year, Barron’s said. Both companies currently rely... More »
PERTH – Australia will intensify testing for the Zika virus in Queensland state where Aedes mosquitoes are found, authorities said on Saturday, adding that two new cases among local residents were the result of travel to affected countries. Queensland’s govern... More »
Companies and scientists are racing to create a Zika vaccine as concern grows over the mosquito-borne virus that has been linked to severe birth defects and is spreading quickly through the Americas. Zika is now present in 23 countries and territories in the A... More »
RENNES, France A man left brain dead after a drug trial in northwest France died on Sunday, said the hospital where he was being treated. The Rennes hospital said in a statement that five other volunteers were in stable condition after they were admitted last ... More »
Martin Shkreli, the pharmaceutical entrepreneur facing U.S. charges of securities fraud, has said he had been the target of legal authorities for his much-criticized drug-price hikes and his over-the-top public persona, the Wall Street Journal reported. Shkrel... More »
MUMBAI Shares in India’s largest drugmaker, Sun Pharmaceutical Industries Ltd, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India’s generic drug industry. The warning comes bare... More »
ZURICH Drug companies have taken too great a share of the benefits of new drug treatments but are moving to different models involving sharing more with health systems and insurers, the head of Swiss-based Novartis was quoted saying on Sunday. “We need to tran... More »
MUMBAI India’s largest drugmaker Sun Pharmaceutical Industries Ltd has been warned by U.S. health regulators for violating manufacturing standards at its Halol plant in India, even as it has been working on fixing issues at the plant for over a year. The U.S. ... More »
SHANGHAI China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population. Given the 10 years or more it typically takes t... More »
DAKAR A one-month-old baby girl who was Guinea’s last reported Ebola case left hospital on Saturday, delighting medical staff and putting the country on course to be declared free of the deadly virus. Guinea will become officially Ebola-free after 42 days if n... More »
LONDON/NEW YORK/FRANKFURT Investment bank Lazard is working with Sanofi’s management to prepare a sale or listing of its Merial animal health unit, aiming to land the leading advisory job for the deal, which could value the business at up 12 billion euros ($12... More »
Pfizer Inc (PFE.N) secured formal board approval on Sunday for its acquisition of Botox maker Allergan Plc (AGN.N) for more than $150 billion, a deal that will create the world’s biggest drug maker, according to people familiar with the matter. The deal, the l... More »
The U.S. Food and Drug Administration said on Friday it approved Baxalta Inc’s drug for use in patients with a type of rare bleeding disorder. The drug, Adynovate, was approved to control and reduce the frequency of bleeding episodes in patients with Hemophili... More »
LONDON British pharmaceutical and biotechnology companies face a major skills shortage which threatens future investment and the long-term success of the life sciences sector, according to a new industry report. The Association of the British Pharmaceutical In... More »
Merck & Co’s drug to reverse the effects of muscle relaxants used in surgery is safe and effective enough to warrant approval, an independent panel to the U.S. Food and Drug Administration said. The drug, which goes by the chemical name of sugammadex, has repe... More »
LONDON Three of Europe’s top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. The unusual confluence of investor days comes at a testing time ... More »
The U.S. Food and Drug Administration said it approved Johnson & Johnson’s chemotherapy to treat specific soft-tissue sarcomas (STS) that have spread to other parts of the body or cannot be removed by surgery. The drug, Yondelis, is designed to delay the progr... More »
BOSTON/NEW YORK A panel of medical experts said on Friday the prices of prescription medicines in the United States need to be brought in line with the value they bring to patients instead of continuing to let drugmakers set any price they choose. “Americans a... More »
Hackers associated with the Chinese government have tried to penetrate at least seven U.S. companies in the three weeks since Washington and Beijing agreed not to spy on each other for commercial reasons, according to a prominent U.S. security firm. CrowdStrik... More »
The U.S. Food and Drug Administration on Friday approved Merck & Co Inc’s immunotherapy, Keytruda, for patients with the most common form of lung cancer whose tumors produce a specific biological marker. The FDA approval for Keytruda in advanced non-small cell... More »
COPENHAGEN Shares in Novo Nordisk (NOVOb.CO) rose as much as 5 percent on Monday after the U.S. Food and Drug Administration (FDA) approved the diabetes drug Tresiba, allowing the Danish drugmaker to prepare its largest ever drug launch. The FDA’s decision lat... More »
The first electronic automatic injector to deliver a drug for the most common form of multiple sclerosis received approval from the U.S. Food and Drug Administration on Friday. The injection delivers Betaseron, a disease-modifying drug approved 22 years ago by... More »
WASHINGTON AstraZeneca LP has agreed to pay $46.5 million and Cephalon Inc [TEVAE.UL] $7.5 million to resolve allegations that the two drug companies underpaid rebates owed under the Medicaid program, the U.S. Justice Department said on Monday. (Reporting by E... More »
